Showing results (1781-1790 of 1,853) with videos related to
Sort By:
Pageof 186
Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamideDarren M Brenner, Gregory S Sayuk, Jessica L Abel, et al.Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Evaluation of a pharmacist-driven medication adherence enhancement serviceSarah N Rinehart, Candyce Collins, Jon Glover, et al.Journal of Managed Care & Specialty Pharmacy|April 26, 2021
Economic burden of growth hormone deficiency in a US pediatric populationPaul Kaplowitz, Janna Manjelievskaia, Lorena Lopez-Gonzalez, et al.Journal of Managed Care & Specialty Pharmacy|March 29, 2023
Economic burden related to fistulas or strictures among commercially insured patients with Crohn's disease in the United StatesYanni Fan, Ling Zhang, Monik C Jiménez, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2025
Health care resource utilization and costs of patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapies across different settings of care: A real-world data analysisAnik R Patel, Ken Hasegawa, Shivani Pandya, et al.Journal of Managed Care & Specialty Pharmacy|October 31, 2025
Halting hyaluronidase hopping to maintain the integrity of Medicare drug price negotiationJohn Kim, Aaron S Kesselheim, Benjamin N RomeJournal of Managed Care & Specialty Pharmacy|July 24, 2025
Real-world use of biologic and targeted synthetic disease-modifying antirheumatic drugs in US patients with psoriatic arthritis: Persistence, patient characteristics associated with discontinuation, and dosing patternsJoseph F Merola, Sarah Welby, Helena Roque, et al.Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Real-world health care costs and resource utilization associated with mild cognitive impairment in the United States: A retrospective cohort study of commercial and Medicare dataFeride H Frech, Gang Li, Timothy R Juday, et al.Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Identifying and characterizing commercially insured patients with HFpEF with high vs low health care resource utilizationJacob Earl, Laura A Hart, Ryan N HansenJournal of Managed Care & Specialty Pharmacy|July 24, 2025
Will the emerging private-label market access channel help or hinder biosimilar market access?Stanton R MehrPageof 186